Merck & Co Inc

(MRK)

Health Care · Pharmaceutical Preparations · US

115.44

+0.2700 (+0.23%)

FINNHUB · 2h ago
Valuation Chart
Financial Statements
EDGAR · 1d ago
Line (USD)FY2025FY2024FY2023FY2022
Revenue65.01B64.17B60.12B59.28B
Pretax Income21.07B19.94B1.89B16.44B
Income Tax2.80B2.80B1.51B1.92B
Net Income18.25B17.12B365.00M14.52B
EPS (diluted)7.286.740.145.71
Diluted Shares2.51B2.54B2.55B2.54B
Interest Expense1.15B962.00M
About

Employees: —
Key Ratios (TTM)
P/E15.79x
EV/EBITDA
EV/Sales4.93x
P/B5.48x
P/FCF23.32x
Operating margin
Net margin28.1 %
ROE34.7 %
Debt / Equity0.89x
Dividend yield
Revenue growth (YoY)1.3 %
EPS growth (YoY)8.0 %
Beta
EDGAR · 1d ago
News
An unhandled error has occurred. Reload 🗙

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.